Davenport & CO LLC Cara Therapeutics, Inc. Transaction History

Davenport & CO LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 09, 2018	SELL	$11.6 - $19.27 $127,356 - $211,565	-10,979 Closed	0 $0
Q1 2018 Apr 04, 2018	SELL	$11.77 - $16.08 $30,013 - $41,003	-2,550 Reduced 18.85%	10,979 $136 Million
Q4 2017 Jan 17, 2018	SELL	$11.86 - $14.08 $6,902 - $8,194	-582 Reduced 4.12%	13,529 $166 Million
Q3 2017 Oct 12, 2017	BUY	$12.6 - $16.34 $177,798 - $230,573	14,111	14,111 $193 Million

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $15M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.